Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Bryan

Showing results (61-70 of 133) with videos related to

Pageof 14
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|May 15, 2026
Pro-inflammatory diet predicts poorer survival in bladder cancer: Results from the bladder cancer prognosis programmeYa-Nan Dai, Benjamin Tura, Evan Yi-Wen Yu, et al.
BJU International|May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancerEvan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Future Oncology (London, England)|February 17, 2016
The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic targetAntonio D Bardoli, Mehran Afshar, Richard Viney, et al.
Pilot and Feasibility Studies|December 9, 2020
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trialHarriet P Mintz, Amandeep Dosanjh, Helen M Parsons, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the <i>TERT</i> 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.
European Urology|May 11, 2021
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Richard T Bryan, James W F Catto, Kieran P Jefferson, et al.
Urology|July 19, 2024
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAlex Sankin, Priya Dave, Louise-Rae Cherrill, et al.
BMJ Open|February 21, 2018
Impact of dietary patterns and the main food groups on mortality and recurrence in cancer survivors: a systematic review of current epidemiological literatureSylvia H J Jochems, Frits H M Van Osch, Richard T Bryan, et al.
Frontiers in Oncology|July 17, 2020
Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC PatientsAnshita Goel, Douglas G Ward, Naheema S Gordon, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Pageof 14

Showing results (61-70 of 133) with videos related to

Sort By:
Pageof 14
Clinical Nutrition (Edinburgh, Scotland)|May 15, 2026
Pro-inflammatory diet predicts poorer survival in bladder cancer: Results from the bladder cancer prognosis programmeYa-Nan Dai, Benjamin Tura, Evan Yi-Wen Yu, et al.
BJU International|May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancerEvan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Future Oncology (London, England)|February 17, 2016
The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic targetAntonio D Bardoli, Mehran Afshar, Richard Viney, et al.
Pilot and Feasibility Studies|December 9, 2020
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trialHarriet P Mintz, Amandeep Dosanjh, Helen M Parsons, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the <i>TERT</i> 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.
European Urology|May 11, 2021
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Richard T Bryan, James W F Catto, Kieran P Jefferson, et al.
Urology|July 19, 2024
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAlex Sankin, Priya Dave, Louise-Rae Cherrill, et al.
BMJ Open|February 21, 2018
Impact of dietary patterns and the main food groups on mortality and recurrence in cancer survivors: a systematic review of current epidemiological literatureSylvia H J Jochems, Frits H M Van Osch, Richard T Bryan, et al.
Frontiers in Oncology|July 17, 2020
Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC PatientsAnshita Goel, Douglas G Ward, Naheema S Gordon, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Pageof 14